Literature DB >> 12502626

Aspirin therapy in diabetes.

John A Colwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12502626     DOI： 10.2337/diacare.26.2007.s87

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  18 in total

1.  [Finding the right platelet anti-aggregant prescription for type-2 diabetes patients, according to the ADA 2003 criteria].

Authors:  Sandra Raméntol Teys; Vicenta Pujol Blaya; Mónica León de la Fuente; María León-Sanromà
Journal:  Aten Primaria       Date:  2006-10-31       Impact factor: 1.137

Review 2.  Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus.

Authors:  S Farhan; I Tentzeris; M K Freynhofer; B Vogel; K Huber
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

Review 3.  Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?

Authors:  K Dahl-Jørgensen; J R Larsen; K F Hanssen
Journal:  Diabetologia       Date:  2005-06-22       Impact factor: 10.122

4.  Clinical determinants of aspirin resistance in diabetes.

Authors:  Hussein N Yassine; Grace Davis-Gorman; Craig S Stump; Stephen S Thomson; Justin Peterson; Paul F McDonagh
Journal:  Diabetes Res Clin Pract       Date:  2010-08-16       Impact factor: 5.602

5.  Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release.

Authors:  Haruhiko Tokuda; Gen Kuroyanagi; Takashi Onuma; Yukiko Enomoto; Tomoaki Doi; Hiroki Iida; Takanobu Otsuka; Shinji Ogura; Toru Iwama; Kumi Kojima; Osamu Kozawa
Journal:  Biomed Rep       Date:  2018-02-06

6.  Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Authors:  Christos Kalofoutis; Christina Piperi; Anastasios Kalofoutis; Fred Harris; David Phoenix; Jaipaul Singh
Journal:  Exp Clin Cardiol       Date:  2007

7.  Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.

Authors:  S G Wannamethee; A G Shaper; L Lennon
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

8.  Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.

Authors:  Samy I McFarlane; Jonathan Castro; Jasjeet Kaur; John J Shin; Douglas Kelling; Amal Farag; Nicole Simon; Fadi El-Atat; Alan Sacerdote; Emad Basta; John Flack; George Bakris; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

Review 9.  Progress and controversies: treating obesity and insulin resistance in the context of hypertension.

Authors:  Janet B McGill; Steven Haffner; Tomas J Rees; James R Sowers; Andrew M Tershakovec; Michael Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-01       Impact factor: 3.738

10.  Should hypertensive patients take aspirin? A report from the Food and Drug Administration.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-03       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.